Mary Jo Burkhard, 71, went to the emergency room with worrying symptoms. It wasn't the heart attack she feared.
Researchers have identified genetic variants linked to pancreatic cancer in Brazilian patients, offering new insights for ...
Theriva Biologics, Inc. recently disclosed the outcomes of a Type D meeting with the U.S. Food and Drug Administration (FDA), outlining details regarding the design of a Phase 3 clinical study ...
This writer sets out a realistic strategy and timeframe for getting to a seven-figure ISA portfolio by investing in the stock ...
Shares of European Opportunities Trust plc (LON:JEO – Get Free Report) were down 2.4% during mid-day trading on Friday . The stock traded as low as GBX 841.44 ($10.73) and last traded at GBX 843 ($10.
Phase 2 trial of petosemtamab in combination with standard chemotherapy in 2L metastatic colorectal cancer (mCRC) enrolling; phase 2 trial in 1L mCRC in combination with standard chemotherapy planned ...